Top CompaniesForm ScreenerCluster BuysSectorsFeedbackFAQBlogNewsletter
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
14 Nov 2023
BAKER BROS. ADVISORS LP
Director
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
165,808+42%
49,387
$158.13
$7,809,558.50
BUY
13 Nov 2023
BAKER BROS. ADVISORS LP
Director
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
159,341+207%
107,499
$146.99
$15,801,021.00
SELL
28 Feb 2023
Waltermire Robert E.
Senior VP, Chief Pharma Dev., Officer
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
8,739-53%
10,000
$273.24
$2,732,438.20
SELL
17 Jan 2023
Levy Richard S
Director
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
31,489-41%
22,489
$293.15
$6,592,686.00
SELL
3 Jan 2023
Lynch Brian Joseph
SVP and General Counsel, Officer
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
12,400-51%
13,000
$282.92
$3,677,976.50
SELL
23 Dec 2022
Lynch Brian Joseph
SVP and General Counsel, Officer
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
6,500-51%
7,000
$274.18
$1,919,230.80
SELL
23 Dec 2022
Sukhija Remy
Chief Commercial Officer, Officer
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
29,407-50%
30,000
$274.14
$8,224,073.00
SELL
17 Aug 2020
BAY CITY CAPITAL LLC
10% Owner
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
42,875-41%
30,000
$109.74
$3,292,196.00
SELL
17 Aug 2020
CRAVES FRED B
Director, 10% Owner
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
42,875-41%
30,000
$109.74
$3,292,196.00
SELL
13 Dec 2019
BAY CITY CAPITAL LLC
10% Owner
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
4,089,702-22%
1,200,000
$105.47
$126,564,010.00
SELL
13 Dec 2019
CRAVES FRED B
Director, 10% Owner
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
4,089,702-22%
1,200,000
$105.47
$126,564,010.00
SELL
21 Nov 2018
MILLIGAN DAVID V
Director
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
0-100%
20,000
$112.54
$2,250,800.00
BUY
20 Nov 2018
FRIEDMAN PAUL A
Chief Executive Officer, Director, Officer
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
161,128+2%
4,000
$117.88
$471,520.00
SELL
19 Nov 2018
MILLIGAN DAVID V
Director
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
20,000-33%
10,000
$131.60
$1,316,000.00
BUY
19 Nov 2018
FRIEDMAN PAUL A
Chief Executive Officer, Director, Officer
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
157,128+2%
4,000
$124.00
$496,000.00
BUY
19 Nov 2018
CRAVES FRED B
Director, 10% Owner
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
296,167+0%
2,000
$124.69
$249,387.00
SELL
11 Jun 2018
Schneebaum Marc R
Chief Financial Officer, Officer
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
41,668-19%
10,099
$287.46
$2,903,058.50
SELL
11 Jun 2018
CRAVES FRED B
Director, 10% Owner
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
5,264,382-4%
268,184
$287.46
$77,092,170.00
SELL
11 Jun 2018
FRIEDMAN PAUL A
Chief Executive Officer, Director, Officer
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
655,540-10%
73,526
$287.46
$21,135,784.00
BUY
11 Jun 2018
Taub Rebecca
Chief Medical Officer, EVP R&D, Director, Officer
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
655,540+12%
73,526
$287.46
$21,135,784.00
SELL
11 Jun 2018
BAY CITY CAPITAL LLC
Director, 10% Owner
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
5,264,382-5%
280,000
$287.46
$80,488,790.00
BUY
23 Aug 2017
Levy Richard S
Director
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
7,200+38%
2,000
$16.12
$32,235.91
BUY
22 Aug 2017
Levy Richard S
Director
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
3,640+3944%
3,550
$16.12
$57,209.06
BUY
21 Aug 2017
Levy Richard S
Director
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
900+133%
3,550
$15.88
$56,358.30
Home
Top CompaniesForm ScreenerSectors
DisclaimersPrivacyTerms of Service
ContactBlogNewsletter